1-3 of 3
Peter W. Thomas
Close
Sort by
Journal Articles

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgV H genes and includes patients with good prognosis, nonnodal disease

Clinical Trials & Observations
Jenny Orchard, Richard Garand, Zadie Davis, Gavin Babbage, Surinder Sahota, Estella Matutes, Daniel Catovsky, Peter W. Thomas, Hervé Avet-Loiseau, David Oscier
Journal: Blood
Blood (2003) 101 (12): 4975–4981.
https://doi.org/10.1182/blood-2002-06-1864
Published: 2003
Journal Articles

Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors

Clinical Trials & Observations
David G. Oscier, Anne C. Gardiner, Sarah J. Mould, Sharron Glide, Zadie A. Davis, Rachel E. Ibbotson, Martin M. Corcoran, Robert M. Chapman, Peter W. Thomas, J. Adrian Copplestone, Jenny A. Orchard, Terry J. Hamblin
Journal: Blood
Blood (2002) 100 (4): 1177–1184.
https://doi.org/10.1182/blood.V100.4.1177.h81602001177_1177_1184
Published: 2002
Journal Articles

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease

Terry J. Hamblin, Jenny A. Orchard, Rachel E. Ibbotson, Zadie Davis, Peter W. Thomas, Freda K. Stevenson, David G. Oscier
Journal: Blood
Blood (2002) 99 (3): 1023–1029.
https://doi.org/10.1182/blood.V99.3.1023
Published: 2002